查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1880791

全球感染控制市場

Infection Control
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 587 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到2030年，全球感染控制市場規模將達834億美元。

全球感染疾病控制市場預計在2024年達到563億美元，預計到2030年將達到834億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為6.8%。本報告分析的細分市場之一－防護屏障，預計將以7.7%的複合年成長率成長，並在分析期間結束時達到348億美元。滅菌產品和服務細分市場預計在分析期間內將以7.0%的複合年成長率成長。

美國市場規模估計為153億美元，而中國市場預計將以8.0%的複合年成長率成長。

預計到2024年，美國感染控制市場規模將達153億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到129億美元，2024年至2030年的複合年成長率（CAGR）為8.0%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率將分別達到5.4%和6.7%。在歐洲，德國預計將以約6.2%的複合年成長率成長。

全球感染控制市場－主要趨勢與促進因素概述

如今，感染控制的範圍和重要性由什麼決定？

感染控制是一項重要的醫學專科，旨在預防或阻止感染在醫療機構和社區的傳播。該領域涵蓋多種用於最大限度降低感染風險的實踐、流程和程序。消毒方法、滅菌程序和衛生習慣用於保護病人和醫護人員。感染控制不僅在醫院至關重要，在診所、療養院和家庭中也同樣重要，尤其是在照顧老年人和免疫力較弱人群的場所。近期發生的全球衛生危機，由於缺乏適當的防治措施導致感染廣泛傳播，凸顯了感染控制的重要性，並強調了採取嚴格有效的感染控制措施的必要性。

為什麼疫情讓我們更深刻地認知到強而有力的感染控制措施的必要性？

新冠疫情大大改變了感染控制格局，為該領域帶來了前所未有的關注和資源投入。世界各地的醫療機構都對感染控制通訊協定進行了審查和更新，以防止病毒在院內外傳播，同時應對激增的患者數量。這種情況加速了感染控制技術的創新，包括紫外線消毒、高效能空氣微粒過濾器（HEPA過濾器）和先進的個人防護工具（PPE）。此外，各國政府和機構加強了對醫護人員感染預防和控制最佳實踐培訓的投入，這不僅對應對當前疫情至關重要，對未來可能發生的疫情也同樣重要。

哪些技術進步正在革新感染控制？

科技在推進感染控制措施方面發揮著至關重要的作用。新型診斷工具的開發使得病原體的快速識別成為可能，使其成為有效感染控制的關鍵組成部分。先進的滅菌技術，例如低溫等離子滅菌，為傳統方法提供了更高效、更安全的替代方案，傳統方法通常涉及有毒化學物質和高溫。一些醫療機構也在應用機器人和自動化技術，以實現比人工清潔更徹底、更一致的房間消毒和設備消毒。此外，資訊科技有助於追蹤和分析數據，從而監測感染率和治療效果，顯著提高感染控制方案的有效性。

推動感染控制市場成長的關鍵因素有哪些？

感染控制市場的成長受多種因素驅動，包括人們對醫療相關感染（HAI）的認知不斷提高、消毒滅菌產品的技術進步以及諸如新冠肺炎疫情等全球性健康危機。提高病人安全和滿足嚴格的監管標準的需求，推動了各醫療機構對有效感染控制解決方案的需求。科技創新催生了更有效、更有效率的感染控制產品，這些產品正被全球醫療機構迅速採用。此外，消費行為的改變，例如醫護人員和公眾衛生意識的提高，也進一步促進了市場成長。

部分：

產品和服務（防護屏障、滅菌產品和服務、清潔消毒產品、內視鏡再處理產品、其他產品和服務），最終用途（醫院和診所、製藥和醫療設備公司、其他最終用途）

受訪公司範例

  • 3M Company
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • bioMerieux SA
  • AliMed, Inc.
  • Baumer SA
  • Ansell Ltd.
  • Allegion PLC
  • Alfred Becht GmbH
  • Belimed AG
  • A-dec Inc.
  • Advanced Sterilization Products
  • Ahlstrom-Munksjo
  • ABC Dentistry &Orthodontics

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Market Glass, Inc. 並沒有查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）預測各公司的競爭地位變化。這種複雜多變的市場現實將對競爭對手產生多方面的影響，包括銷貨成本增加、盈利下降以及供應鏈重組。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP12704

Global Infection Control Market to Reach US$83.4 Billion by 2030

The global market for Infection Control estimated at US$56.3 Billion in the year 2024, is expected to reach US$83.4 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Protective Barriers, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$34.8 Billion by the end of the analysis period. Growth in the Sterilization Products & Services segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$15.3 Billion While China is Forecast to Grow at 8.0% CAGR

The Infection Control market in the U.S. is estimated at US$15.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$12.9 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.4% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Infection Control Market - Key Trends & Drivers Summarized

What Defines the Scope and Importance of Infection Control Today?

Infection control is a critical discipline within healthcare that aims to prevent or stop the spread of infections in healthcare facilities and communities. This field encompasses various practices, processes, and procedures used to minimize the risk of infection. It involves the use of disinfection methods, sterilization procedures, and sanitation practices to protect patients and healthcare workers alike. Infection control is essential not only in hospitals but also in other settings such as clinics, nursing homes, and at home, especially when caring for the elderly or those with weakened immune systems. The significance of infection control has been underscored by recent global health crises, where the lack of proper practices led to widespread outbreaks, highlighting the need for stringent and effective infection control measures.

How Have Pandemics Reinforced the Necessity for Robust Infection Control Measures?

The COVID-19 pandemic has dramatically transformed the landscape of infection control, bringing unprecedented attention and resources to this field. Healthcare facilities worldwide have revised and updated their infection control protocols to handle the surge in patients while preventing the spread of the virus within and beyond their walls. This situation has accelerated innovation in infection control technologies, such as UV-C disinfection, HEPA filters, and advanced personal protective equipment (PPE). Moreover, it has led to increased governmental and institutional investments in training healthcare workers in the best practices for infection prevention and control, which is critical in managing not only the current pandemic but also future outbreaks.

Which Technological Innovations Are Revolutionizing Infection Control?

Technology plays a pivotal role in advancing infection control measures. The development of new diagnostic tools has enabled faster identification of pathogens, which is crucial for effective infection control. Advanced sterilization technology, such as low-temperature plasma sterilization, offers more efficient and safer alternatives to traditional methods, which often involved toxic chemicals or high heat. Robotics and automation have also been introduced in some healthcare settings to decontaminate rooms and equipment more thoroughly and consistently than manual cleaning. Furthermore, information technology has facilitated better tracking and data analysis to monitor infection rates and outcomes, significantly enhancing infection control programs' effectiveness.

What Are the Major Drivers of Growth in the Infection Control Market?

The growth in the infection control market is driven by several factors, including increased awareness of healthcare-associated infections (HAIs), technological advancements in sterilization and disinfection products, and global health crises such as the COVID-19 pandemic. There is a growing demand for effective infection control solutions across various healthcare settings, driven by the need to improve patient safety and meet stringent regulatory standards. Technological innovations have led to the development of more effective and efficient infection control products, which are being rapidly adopted by healthcare facilities worldwide. Additionally, shifts in consumer behavior, particularly the increased emphasis on sanitation and hygiene practices observed in both healthcare workers and the general public, are further propelling the market growth.

SCOPE OF STUDY:

The report analyzes the Infection Control market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Products & Services (Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products, Other Products & Services); End-Use (Hospitals & Clinics, Pharma & Medical Device Companies, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 145 Featured) -

  • 3M Company
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • bioMerieux SA
  • AliMed, Inc.
  • Baumer SA
  • Ansell Ltd.
  • Allegion PLC
  • Alfred Becht GmbH
  • Belimed AG
  • A-dec Inc.
  • Advanced Sterilization Products
  • Ahlstrom-Munksjo
  • ABC Dentistry & Orthodontics

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Infection Control - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Market Analysis and Prospects
    • Product and End-use Segments
    • Regional Market Analysis
    • Market Growth Restraining Factors
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Sterilization Equipment Market Witnesses Rapid Growth
    • Major Players in the Global Sterilization Equipment Market
    • Low-Temperature Sterilization Gains Ground
    • Leading Players in the Low-Temperature Sterilization Market
    • Emergence of Outsourcing Trend Bodes Well for Sterilization Services
    • E-beam Sterilization of Medical Devices Registers Rapid Growth
    • Endoscope Contamination - A Major Health Hazard Driving the Demand for Sterilization Equipment
    • Increasing Need to Reduce Hospital-Acquired Infections Propel Market Demand
    • Leading Nosocomial Infections in the US: Percentage Breakdown of Healthcare Cost by Infection Type
    • Government Support to Ensure Infection Control in Clinical Settings to Boost Demand for Infection Control Products
    • Increasing Prevalence of Chronic Disorders, Rise in Surgical Procedures and the Need to Prevent Transmission of Infections Fuels Market Growth
    • Aging Population - A Key Growth Driver
    • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Rising Demand for Medical Devices Augurs Well for the Market
    • Surgical Drapes and Gowns: Indispensable for Safe Healthcare
    • Surgical Gowns Market: Stable Growth Outlook
    • High Demand for Disposable Drapes and Gowns
    • Growth in Medical Device Reprocessing to Offer New Areas of Growth
    • Improving Healthcare Expenditure to Bode Well for Market Growth
    • Technological Advancements
    • Sealive's Biovector Sterilization Technology for more Effective Inactivation of Viruses and Microorganisms
    • Introduction of Business-Friendly Policies and Guidelines Fuel Demand for Eco-Friendly Medical Sterilization Equipment
    • Challenges and Future Prospects
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Protective Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Protective Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Protective Barriers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Sterilization Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Sterilization Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Sterilization Products & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cleaning & Disinfection Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cleaning & Disinfection Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cleaning & Disinfection Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Endoscope Reprocessing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Endoscope Reprocessing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Endoscope Reprocessing Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Other Products & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Pharma & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Infection Control Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION